Page 1 sur 1

Syndrome myasthénique congénital: spectre de mutations dans une cohorte indienne

Posté : 01 sept. 2018 11:39
par Pboulanger
:hi:

:arrow: Lu sur :https://www.ncbi.nlm.nih.gov/pubmed/30124556

[hr][/hr]

Traduction disponible directement en cliquant en bas à droite de ce message sur l'expression Traduire en

Image

[hr][/hr]

Congenital Myasthenic Syndrome: Spectrum of Mutations in an Indian Cohort.
Selvam P1, Arunachal G1, Danda S1, Chapla A2, Sivadasan A3, Alexander M3, Thomas MM3, Thomas NJ2.
J Clin Neuromuscul Dis. 2018 Sep;20(1):14-27. doi: 10.1097/CND.0000000000000222.


Abstract
  • OBJECTIVES:

    To investigate the mutational spectrum and genotype-phenotype correlation in Indian patients with congenital myasthenic syndrome (CMS), using next-generation sequencing of 5 genes.
  • METHODS:

    CHRNE, COLQ, DOK7, RAPSN, and GFPT1 were sequenced in 25 affected patients.
  • RESULTS:

    We found clinically significant variants in 18 patients, of which variants in CHRNE were the most common, and 9 were novel. A common pathogenic COLQ variant was also detected in 4 patients with isolated limb-girdle congenital myasthenia.
  • CONCLUSIONS:

    Targeted screening of 5 genes is an effective alternate test for CMS, and an affordable one even in a developing country such as India. In addition, we recommend that patients with isolated limb-girdle congenital myasthenia be screened initially for the common COLQ pathogenic variant. This study throws the first light on the genetic landscape of CMSs in India
.

Message d' un membre de l'équipe technique
Pour les utilisateurs d'I-phone
ci-dessous le lien vers Google Trad

https://translate.google.fr/translate?h ... 2F30124556
Message d' un membre de l'équipe technique
Nous utilisons des services automatiques de traduction fournis
par Yandex ou Google.
Soyez vigilant sur le risque de contre-sens inhérent à ce genre d'outils.